Immunology News

A European clinical stage biotech company announced dosing of the first patient in cohort 2 of its ongoing phase 1/2 GATEWAY clinical trial of lead candidate VTX-801 to treat Wilson’s disease.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

Weighing the potential benefits for two different kidney patient populations, a review board for the FDA voted 13-3 to approve use of the anemia drug daprodustat for patients with dialysis-dependent chronic kidney disease.

Healio spoke with John D. Scott, MD, MSc, FIDSA, chief digital health officer at UW Medicine, professor of allergy and infectious diseases at University of Washington and medical director at the Liver Clinic at Harborview Medical Center, to learn more about what PCPs can do to help prevent and screen for HDV.

The WHO has reported at least 169 cases of severe, acute hepatitis in children aged 1 month to 16 years from a dozen countries worldwide, according to a statement from the organization.

The CDC’s Advisory Committee on Immunization Practices recently issued a universal recommendation that all adults aged 19 to 59 years receive the hepatitis B vaccine.

Healio Gastroenterology and Hepatology presents the following report on highlights from The Liver Meeting Digital Experience.

According to a presenter at The Liver Meeting Digital Experience, diagnosis and treatment for hepatitis B virus remains low; therefore, significant increases in treatment are needed to decrease disease burden.

Increased hepatic steatosis was observed among responders who arrived earlier at the World Trade Center site, according to a study published in American Journal of Industrial Medicine.